In the treatment of various coronary artery diseases (CAD) for select indications Especially valuable for young patients with multiple blocks & underlying conditions that may render angioplasty procedures with drug-eluting stents ineffective International cardiologists are endorsing the use of special drug-coated balloons as a fit
For the treatment of Small Vessel Indication in Coronary Arteries Concept Medical Inc. (CMI), a global leader in drug delivery devices, has received its third Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) for its novel Sirolimus-Coated Balloon, Magic Touch SCB,
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective At a time when coronary diseases are on the rise in India and globally, special drug-coated balloons are emerging as a
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective At a time when coronary diseases are on the rise in India and globally, special drug-coated balloons are emerging as a
In BTK indication for its Sirolimus Coated Balloon Magic Touch PTA Concept Medical Inc. (CMI) is granted the second Investigational Device Exemption (IDE) approval in Below the Knee (BTK) indication, for its Sirolimus Coated Balloon Magic Touch PTA. This came after the company got its first
